Gleisner Ana L, Jung HeeSoo, Lentine Krista L, Tuttle-Newhall Janet
Division of Abdominal Organ Transplantation, Department of Surgery, Saint Louis University Medical Center, St. Louis, MO.
J Nephrol Ther. 2012;Suppl 4(SI Kidney Transplantation). doi: 10.4172/2161-0959.S4-006. Epub 2012 Mar 30.
Renal dysfunction is a common comorbidity in patients with liver failure and is a well-established predictor of both morbidity and mortality among patients awaiting liver transplantation. The etiology of renal failure in patients with cirrhosis can be functional, structural, or represent a combination of potentially reversible physiologic changes and permanent histologic damage. Diagnostic criteria for acute and chronic kidney disease have been established, but cirrhosis poses challenges for accurate assessment of renal function with conventional clinical methods such as serum creatinine and creatinine-based estimating equations. Renal biopsies can have an important role for defining permanent structural damage as part of the pre-transplant evaluation of patients with liver disease; however, coagulopathy, portal hypertension and ascites increase the risk of biopsy-associated complications in cirrhotic patients. While renal dysfunction due to hepatorenal physiology is potentially reversible after liver transplantation, simultaneous kidney liver transplantation and kidney after liver transplant can also improve outcomes in a subset of patients with irreversible renal injury.
肾功能障碍是肝衰竭患者常见的合并症,并且是等待肝移植患者发病率和死亡率的既定预测指标。肝硬化患者肾衰竭的病因可能是功能性的、结构性的,或者是潜在可逆的生理变化和永久性组织学损伤的组合。急性和慢性肾病的诊断标准已经确立,但肝硬化给使用血清肌酐和基于肌酐的估算方程等传统临床方法准确评估肾功能带来了挑战。肾活检在确定永久性结构损伤方面可发挥重要作用,作为肝病患者移植前评估的一部分;然而,凝血功能障碍、门静脉高压和腹水会增加肝硬化患者活检相关并发症的风险。虽然肝肾功能生理导致的肾功能障碍在肝移植后可能是可逆的,但同期肝肾联合移植和肝移植后肾移植也可以改善一部分有不可逆肾损伤患者的预后。